{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T20:29:12Z","timestamp":1775420952359,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Urinary tract cancers including bladder, kidney, ureter, and pelvis are a common malignancy worldwide with high mortality ratio. Aimed to investigate the prevalence of these cancers, we conducted this study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, all the information related to ICD10 codes, gender, age and province of residence of individuals were obtained from the data of Iran\u2019s cancer registry by the Ministry of Health, Medicine and Medical Education and demographic evidence for each sub-country from the reports of Statistics Center of Iran (SCI). Also, the data of two Iranian national survey studies CASPIAN-III, IV, and V (information related to the care and prevention of non-communicable diseases (NCD) in childhood and adolescence) and STEPs (including information on NCD in adults over 18 years old) were used. The data was analyzed using Poisson regression with mixed effects to estimate the incidence of cancers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Bladder and kidney neoplasm are the most common cancers of the urinary system in Iran. The prevalence of bladder cancer has increased from 5.82 to 11.50 per 100,000 individuals. The increasing trend is growing faster in men compared with women. The incidence of kidney neoplasm has increased over the years (2.03 in 2005 vs. 7.02 in 2020 per 100,000). Having a higher incidence ratio compared with bladder cancer, kidney cancer is responsible for 35.06% of all urinary cancers in 2020 compared with 23.71% in 2005. Both neoplasms of the ureter and renal pelvis were recorded rarely and with lower incidence in both sexes during this period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Considering the increasing trend in the incidence of urinary neoplasms in Iran during these years, the advantage of focusing on the risk of urinary cancers is highlighted. Therefore, investigating the prevalence and incidence of urinary cancers to plan and manage these cancers will result in prevention and reduction of the disease burden on the Iranian society. Future studies in this field can help in the prevention and well-timed diagnosis of these cancers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12939-023-02084-1","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T19:02:11Z","timestamp":1705950131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The 15-year national trends of urinary cancers incidence among Iranian men and women; 2005\u20132020"],"prefix":"10.1186","volume":"23","author":[{"given":"Amir-Hossein","family":"Mousavian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Shafiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Sheidaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges Zargar","family":"Balajam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiya","family":"Gohari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisam","family":"Aryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ghanbari-Motlagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Ostovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad Kazem","family":"Aghamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Heshmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"issue":"6","key":"2084_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","volume":"78","author":"JY-C Teoh","year":"2020","unstructured":"Teoh JY-C, Huang J, Ko WY-K, Lok V, Choi P, Ng C-F, et al. Global trends of Bladder cancer incidence and mortality, and their associations with Tobacco use and gross domestic product per capita. Eur Urol. 2020;78(6):893\u2013906.","journal-title":"Eur Urol"},{"issue":"3","key":"2084_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"3","key":"2084_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4103\/2249-4863.197258","volume":"5","author":"JP Yaxley","year":"2016","unstructured":"Yaxley JP. Urinary tract cancers: an overview for general practice. J Family Med Prim care. 2016;5(3):533.","journal-title":"J Family Med Prim care"},{"issue":"6","key":"2084_CR4","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","volume":"178","author":"MC Hall","year":"2007","unstructured":"Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, et al. Guideline for the management of nonmuscle invasive Bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 2007;178(6):2314\u201330.","journal-title":"J Urol"},{"issue":"1","key":"2084_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupr\u00eat","year":"2018","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, Zigeuner R, Sylvester RJ, Burger M, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73(1):111\u201322.","journal-title":"Eur Urol"},{"issue":"6","key":"2084_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","volume":"74","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of Bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784\u201395.","journal-title":"Eur Urol"},{"issue":"8","key":"2084_CR7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","volume":"118","author":"KF Brown","year":"2018","unstructured":"Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130\u201341.","journal-title":"Br J Cancer"},{"issue":"5","key":"2084_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/0090-4295(82)90601-X","volume":"19","author":"BN Nocks","year":"1982","unstructured":"Nocks BN, Heney NM, Dally JJ, Perrone TA, Griffin PP, Prout GR Jr. Transitional cell carcinoma of renal pelvis. Urology. 1982;19(5):472\u20137.","journal-title":"Urology"},{"issue":"1","key":"2084_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2084_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"Cancer J Clin"},{"issue":"8","key":"2084_CR11","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney L. The global burden of urinary Bladder cancer: an update. World J Urol. 2020;38(8):1895\u2013904.","journal-title":"World J Urol"},{"issue":"6","key":"2084_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ncpuro0510","volume":"3","author":"C Pelucchi","year":"2006","unstructured":"Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanisms of Disease: the epidemiology of Bladder cancer. Nat Clin Pract Urol. 2006;3(6):327\u201340.","journal-title":"Nat Clin Pract Urol"},{"issue":"1","key":"2084_CR13","doi-asserted-by":"publisher","first-page":"1762473","DOI":"10.1080\/2162402X.2020.1762473","volume":"9","author":"N Shao","year":"2020","unstructured":"Shao N, Tang H, Mi Y, Zhu Y, Wan F, Ye D. A novel gene signature to predict immune infiltration and outcome in patients with Prostate cancer. Oncoimmunology. 2020;9(1):1762473.","journal-title":"Oncoimmunology"},{"key":"2084_CR14","doi-asserted-by":"crossref","unstructured":"Ghamari ZT. Cancers of urinary system; prevalence, demographic. Jundishapur J Chronic Disease Care. 2019;8(4).","DOI":"10.5812\/jjcdc.95732"},{"key":"2084_CR15","unstructured":"Zhang Z. Multiple imputation for time series data with Amelia package. Annals of Translational Medicine. 2016;4(3)."},{"key":"2084_CR16","doi-asserted-by":"crossref","unstructured":"Hastie T, Tibshirani R, Friedman JH, Friedman JH. The elements of statistical learning: data mining, inference, and prediction. Springer; 2009.","DOI":"10.1007\/978-0-387-84858-7"},{"issue":"3","key":"2084_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420\u201344.","journal-title":"JAMA Oncol"},{"key":"2084_CR18","unstructured":"amar.org. Population and Housing Censuses 2016; Available from: https:\/\/www.amar.org.ir\/english\/Population-and-Housing-Censuses."},{"issue":"5","key":"2084_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/2041-210X.12179","volume":"5","author":"E Shyu","year":"2014","unstructured":"Shyu E, Caswell H. Calculating second derivatives of population growth rates for ecology and evolution. Methods Ecol Evol. 2014;5(5):473\u201382.","journal-title":"Methods Ecol Evol"},{"key":"2084_CR20","unstructured":"Djalalinia S, Modirian M, Sheidaei A, Yoosefi M, Zokaiee H, Damirchilu B, et al. Protocol design for large\u2013scale cross\u2013sectional studies of surveillance of risk factors of non\u2013communicable Diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9):\u2013."},{"issue":"1","key":"2084_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.15171\/jcvtr.2017.02","volume":"9","author":"R Kelishadi","year":"2017","unstructured":"Kelishadi R, Heshmat R, Farzadfar F, Motlag ME, Bahreynian M, Safiri S, et al. Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: the CASPIAN-III Study. J Cardiovasc Thorac Res. 2017;9(1):12.","journal-title":"J Cardiovasc Thorac Res"},{"issue":"4","key":"2084_CR22","first-page":"444","volume":"40","author":"T Beal","year":"2019","unstructured":"Beal T, Morris SS, Tumilowicz A. Global patterns of adolescent fruit, vegetable, carbonated soft drink, and fast-food consumption: a meta-analysis of global school-based student health surveys. FoodNutr Bull. 2019;40(4):444\u201359.","journal-title":"FoodNutr Bull"},{"issue":"1","key":"2084_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF03032212","volume":"21","author":"L Smith","year":"2004","unstructured":"Smith L, Hyndman RJ, Wood SN. Spline interpolation for demographic variables: the monotonicity problem. J Popul Res. 2004;21(1):95\u20138.","journal-title":"J Popul Res"},{"key":"2084_CR24","doi-asserted-by":"crossref","unstructured":"Agresti A. Analysis of ordinal categorical data. John Wiley & Sons; 2010.","DOI":"10.1002\/9780470594001"},{"issue":"1","key":"2084_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12889-023-15417-0","volume":"23","author":"G Shafiee","year":"2023","unstructured":"Shafiee G, Mousavian A-h, Sheidaei A, Ebrahimi M, Khatami F, Gohari K, et al. The 15-year national trends of genital cancer incidence among Iranian men and women; 2005\u20132020. BMC Public Health. 2023;23(1):495. 2023\/03\/15;.","journal-title":"BMC Public Health"},{"issue":"218","key":"2084_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/03008880802283664","volume":"Sep","author":"P Boffetta","year":"2008","unstructured":"Boffetta P. Tobacco Smoking and risk of Bladder cancer. Scand J Urol Nephrol Suppl. 2008;Sep(218):45\u201354.","journal-title":"Scand J Urol Nephrol Suppl"},{"issue":"1","key":"2084_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/MOU.0000000000000453","volume":"28","author":"F Soria","year":"2018","unstructured":"Soria F, Marra G, \u010capoun O, Soukup V, Gontero P. Prevention of Bladder cancer incidence and recurrence: Tobacco use. Curr Opin Urol. 2018;28(1):80\u20137.","journal-title":"Curr Opin Urol"},{"key":"2084_CR28","doi-asserted-by":"crossref","unstructured":"Sabahy AR, Divsalar K, Bahreinifar S, Marzban M, Nakhaee N. Waterpipe Tobacco use among Iranian university students: correlates and perceived reasons for use. Int J Tuberc Lung Dis. 2011 \/\/;15(6):844\u20137.","DOI":"10.5588\/ijtld.10.0744"},{"key":"2084_CR29","doi-asserted-by":"crossref","unstructured":"Sabzmakan L, Ghasemi M, Asghari Jafarabadi M, Kamalikhah T, Chaleshgar Kordasiabi M. Factors Associated with Tobacco Use among Iranian adolescents: an application of Protection Motivation Theory. Substance Use & Misuse. 2018 2018\/07\/29;53(9):1511\u20138.","DOI":"10.1080\/10826084.2017.1415356"},{"issue":"1","key":"2084_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder Cancer incidence and mortality: A global overview and recent trends. Eur Urol. 2017;71(1):96\u2013108.","journal-title":"Eur Urol"},{"issue":"8","key":"2084_CR31","first-page":"507","volume":"96","author":"KC DeGeorge","year":"2017","unstructured":"DeGeorge KC, Holt HR, Hodges SC. Bladder Cancer: diagnosis and treatment. Am Fam Physician. 2017;96(8):507\u201314.","journal-title":"Am Fam Physician"},{"issue":"7","key":"2084_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2011.1142","volume":"306","author":"ND Freedman","year":"2011","unstructured":"Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between Smoking and risk of Bladder cancer among men and women. JAMA. 2011;306(7):737\u201345.","journal-title":"JAMA"},{"key":"2084_CR33","doi-asserted-by":"crossref","unstructured":"Botelho MC, Alves H, Richter J. Halting Schistosoma haematobium - associated Bladder cancer. Int J Cancer Manag. 2017;10(9).","DOI":"10.5812\/ijcm.9430"},{"key":"2084_CR34","unstructured":"Lackey EK, Horrall S, Schistosomiasis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022. StatPearls Publishing LLC.; 2022."},{"issue":"11","key":"2084_CR35","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1017\/S0031182016000883","volume":"143","author":"S Khademvatan","year":"2016","unstructured":"Khademvatan S, Salmanzadeh S, Foroutan-Rad M, Ghomeshi M. Elimination of urogenital schistosomiasis in Iran: past history and the current situation. Parasitology. 2016;143(11):1390\u20136.","journal-title":"Parasitology"},{"key":"2084_CR36","unstructured":"Eriksen MP, Mackay J, Ross H. The Tobacco atlas. Citeseer; 2012."},{"issue":"1","key":"2084_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/MOU.0000000000000454","volume":"28","author":"R Tahbaz","year":"2018","unstructured":"Tahbaz R, Schmid M, Merseburger AS. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol. 2018;28(1):62\u201379.","journal-title":"Curr Opin Urol"},{"issue":"5","key":"2084_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrurol.2010.46","volume":"7","author":"WH Chow","year":"2010","unstructured":"Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7(5):245\u201357.","journal-title":"Nat Rev Urol"},{"issue":"3","key":"2084_CR39","first-page":"179","volume":"99","author":"RE Gray","year":"2019","unstructured":"Gray RE, Harris GT. Renal cell carcinoma: diagnosis and management. Am Fam Physician. 2019;99(3):179\u201384.","journal-title":"Am Fam Physician"},{"issue":"1","key":"2084_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.euf.2020.12.020","volume":"8","author":"J Huang","year":"2022","unstructured":"Huang J, Leung DK, Chan EO, Lok V, Leung S, Wong I, et al. A Global Trend analysis of kidney Cancer incidence and mortality and their associations with Smoking, Alcohol Consumption, and metabolic syndrome. Eur Urol Focus. 2022;8(1):200\u20139.","journal-title":"Eur Urol Focus"},{"issue":"3","key":"2084_CR41","first-page":"286","volume":"90","author":"M Mohammadian","year":"2017","unstructured":"Mohammadian M, Pakzad R, Towhidi F, Makhsosi BR, Ahmadi A, Salehiniya H. Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012. Clujul Med. 2017;90(3):286\u201393.","journal-title":"Clujul Med"},{"key":"2084_CR42","doi-asserted-by":"publisher","first-page":"101692","DOI":"10.1016\/j.canep.2020.101692","volume":"65","author":"J Tempo","year":"2020","unstructured":"Tempo J, Logan C, O\u2019Callaghan M, Kahokehr A, Kichenadasse G, D\u2019Onise K, et al. Bladder, penile, renal pelvis and testis cancers: a population based analysis of incidence and survival 1977\u20132013. Cancer Epidemiol. 2020;65:101692.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"2084_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/bju.14533","volume":"123","author":"IM Michalek","year":"2019","unstructured":"Michalek IM, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, et al. Occupation and risk of cancer of the renal pelvis in nordic countries. BJU Int. 2019;123(2):233\u20138.","journal-title":"BJU Int"}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-023-02084-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-023-02084-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-023-02084-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T19:02:29Z","timestamp":1705950149000},"score":1,"resource":{"primary":{"URL":"https:\/\/equityhealthj.biomedcentral.com\/articles\/10.1186\/s12939-023-02084-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1186\/s12939-023-02084-1","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We hereby declare that no human experiment was involved in our work and that this study is only based on data gathered form cancer registries and that data collection process was performed in accordance with relevant guidelines and regulations. This study was authorized by the ethical committee of Tehran University of Medical Sciences (IR.TUMS.VCR.REC.1398.218). Recruited participants\u2019 data is protected by all authors. No individual data is reported since results are created using statistical modeling. Participants also provided informed consents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}